You have 9 free searches left this month | for more free features.

adt

Showing 1 - 21 of 21

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Trial in Chicago (Docetaxel, ADT, Abiraterone)

Not yet recruiting
  • Prostate Cancer
  • Chicago, Illinois
    Northwestern University
Sep 27, 2023

Metastatic Hormone-sensitive Prostate Cancer Trial in United States (Darolutamide (BAY1841788, Nubeqa), ADT)

Recruiting
  • Metastatic Hormone-sensitive Prostate Cancer
  • Darolutamide (BAY1841788, Nubeqa)
  • ADT
  • Homewood, Alabama
  • +11 more
Jan 13, 2023

Treatment Trial in Shanghai (ADT, SBRT)

Recruiting
  • Treatment
  • ADT
  • SBRT
  • Shanghai, Shanghai, China
    Changhai hospital
Aug 9, 2022

Prostate Cancer Trial (PSMA-radioguided surgery, ADT)

Not yet recruiting
  • Prostate Cancer
  • PSMA-radioguided surgery
  • ADT
  • (no location specified)
Sep 22, 2022

Prostate Cancer Trial (ADT, Enzalutamide, Talazoparib)

Not yet recruiting
  • Prostate Cancer
  • ADT
  • +4 more
  • (no location specified)
May 15, 2023

Recurrent Prostate Cancer Trial in Salisbury, Winston-Salem (MGE, Placebo, ADT)

Recruiting
  • Recurrent Prostate Cancer
  • Salisbury, North Carolina
  • +1 more
Nov 2, 2022

Prostate Cancer Trial in Worldwide (ODM-201, ADT)

Active, not recruiting
  • Prostate Cancer
  • Brussels, Belgium
  • +11 more
Jun 9, 2022

Prostatic Tumor Trial (AAA617, AAA517, Piflufolastat F 18)

Not yet recruiting
  • Prostatic Neoplasm
  • (no location specified)
Apr 27, 2023

Cancer Of Prostate, Prostate Tumors Trial run by the National Cancer Institute (NCI) (ADT, Prednisone, M7824)

Recruiting
  • Cancer Of Prostate
  • Prostate Neoplasms
  • ADT
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Prostate Cancer Trial in Brazil (Apalutamide, Abiraterone, ADT)

Completed
  • Prostate Cancer
  • Salvador, Bahia, Brazil
  • +13 more
Jul 5, 2021

Neoadjuvant Therapy, High Risk Prostate Cancer, Locally Advanced Prostate Cancer Trial in Nanjing (ADT, Abiraterone Acetate,

Recruiting
  • Neoadjuvant Therapy
  • +3 more
  • ADT
  • +8 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
Aug 12, 2022

Biochemically Recurrent Prostate Cancer Trial in Worldwide (Darolutamide (BAY1841788, Nubeqa), Placebo matching darolutamide,

Not yet recruiting
  • Biochemically Recurrent Prostate Cancer
  • Darolutamide (BAY1841788, Nubeqa)
  • +2 more
  • Phoenix, Arizona
  • +183 more
Mar 21, 2023

Prostate Cancer Metastatic Trial in Herlev (procedure, radiation, drug)

Recruiting
  • Prostate Cancer Metastatic
  • RARP
  • +2 more
  • Herlev, Denmark
    Herlev and Gentofte Hospital
Feb 10, 2020

Prostate Cancer Trial in Baltimore, Boston (Docetaxel, Bevacizumab, ADT)

Completed
  • Prostate Cancer
  • Baltimore, Maryland
  • +2 more
Apr 27, 2017

Major Depression Disorder Trial in Worldwide (Adjunct brexpiprazole, ADT)

Completed
  • Major Depression Disorder
  • Adjunct brexpiprazole
  • ADT
  • Arcadia, California
  • +33 more
Jul 11, 2017

MDD Trial in Worldwide (Placebo, Brexpiprazole, ADT)

Completed
  • Major Depressive Disorder
  • Placebo
  • +2 more
  • Little Rock, Arkansas
  • +106 more
Jul 11, 2017

MDD Trial in United States (OPC-34712, Placebo, ADT)

Completed
  • Major Depressive Disorder
  • Arcadia, California
  • +49 more
Feb 2, 2016

MDD (MDD) Trial in United States (ADT, Brexpiprazole)

Completed
  • Major Depressive Disorder (MDD)
  • Garden Grove, California
  • +23 more
Nov 30, 2015

MDD Trial in United States (OPC-34712, Placebo, ADT)

Completed
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +42 more
Sep 30, 2015

MDD Trial in United States (ADT, OPC-34712)

Completed
  • Major Depressive Disorder
  • Arcadia, California
  • +31 more
Oct 6, 2015

Castration-resistant Prostate Cancer Trial in Seoul (ADT, No ADT)

Unknown status
  • Castration-resistant Prostate Cancer
  • ADT
  • No ADT
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 7, 2011